Cat.#: ASSD-103
| Description | DAPI is a blue fluorescent DNA stain which is cell permeant at high concentrations. This is a ready made 1mg/mL staining solution. It is recommended to dilute this solution 1:1000 with your desired buffer for a 1µg/mL working concentration. 0.1µg/mL-10µg/mL is the typical working concentration used in most applications. DAPI also available. |
| Size | 1 mL, 5 mL, |
| Applications | The product is commonly used for cell imaging, cell counting, cell sorting (based on DNA content), apoptosis analysis, and HCA (high content analysis). |
| Chemical Name | 4',6-Diamidino-2-phenylindole dihydrochloride |
| Molecule Weight | 350.24 |
| Molecular formula | C16H15N5.2HCl |
| CAS Number | 28718-90-3 |
| Purity | >98% |
| Form | Pale yellow solution |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Important | When using this product for the first time, aliquot the DAPI ready-made solution and store at -20°C to avoid repeated freezing and thawing. Additionally, We strongly recommend storing this solution in the dark and away from light due to the compound's light sensitivity. |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-113 | Thionin acetate salt (AC113) | 5 g | inquiry |
| ASSD-202 | 5(6)-Carboxytetramethylrhodamine (AC202) | 100 mg, 250 mg | inquiry |
| ASSD-221 | Antifade Fluorescence Mounting Medium with DAPI (hard set) (AC221) | 10 mL | inquiry |
| ASSD-178 | 5-(Iodoacetamido)fluorescein (AC178) | 25 mg, 100 mg, 250 mg | inquiry |
| ASSD-130 | Calcein-AM (AC130) | 1 mg | inquiry |
| ASSD-183 | 5-(4,6-Dichloro-s-triazin-2-ylamino)fluorescein hydrochloride (AC183) | 100 mg | inquiry |
| ASSD-114 | Acridine Orange hydrochloride (AC114) | 50 mg | inquiry |
| ASSD-192 | 4-Fluoro-7-nitrobenzofurazan (AC192) | 5 mg, 25 mg, 50 mg | inquiry |
| ASSD-207 | NBD-X acid (AC207) | 1 g | inquiry |
| ASSD-213 | Fluorescein 6-Maleimide (AC213) | 25 mg, 250 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.